GlassScriptPhysician profile
Maneesh Mehan
NPI 1386751949
$2,540.13
in general payments reported to CMS, 2019-2025
19 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $142 · 2021: $137 · 2022: $1,426 · 2023: $172 · 2024: $116 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401 · Gift: $36.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.97 |
| Gift | $36.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,362.50 | 2019-2024 | Clareon, Centurion, Hydrus Microstent |
| Carl Zeiss Meditec USA, INC. | $322.92 | 2022-2025 | Visumax |
| Biotissue Holdings INC. | $181.19 | 2022-2025 | |
| Sight Sciences, INC. | $97.70 | 2021 | |
| Horizon Therapeutics Plc | $79.80 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $63.46 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $59.82 | 2025 | |
| Shire North American Group INC | $57.58 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.97 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $42.74 | 2022-2023 | Vyzulta |
| Aerie Pharmaceuticals, INC. | $35.93 | 2019 | |
| Eyevance Pharmaceuticals LLC | $29.19 | 2019-2022 | |
| Allergan, INC. | $28.86 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $24.43 | 2019 | |
| Thea Pharma INC. | $23.99 | 2025 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $21.33 | 2020 | |
| Oyster Point Pharma, INC. | $19.61 | 2022 | |
| Rxsight INC | $18.71 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Light Adjustable Lens (Rxlal) |
| Abbvie INC. | $16.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maneesh Mehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.